- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Early Breast Cancer (Phase 2)
Total 12096 results
-
Eli Lilly and CompanyCompletedBreast Cancer | Early-Stage Breast Carcinoma | Hormone Receptor Positive TumorUnited States, Canada, Korea, Republic of, Italy, Austria, Belgium, Germany, Netherlands, Spain, Taiwan
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South KoreaRecruitingBreast Cancer Stage I | Breast Cancer Stage II | Acupuncture | Breast Cancer Stage III | Chemotherapy-induced Peripheral Neuropathy | Early-stage Breast CancerUnited States
-
Rajavithi HospitalRecruitingEarly Stage Breast CancerThailand
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Breast Cancer Research FoundationCompletedEarly Stage Breast CancerUnited States
-
Nevada Cancer InstituteVonsUnknownEarly Stage Breast Cancer (Stage 0-III)United States
-
Azienda Socio Sanitaria Territoriale degli Spedali...Ospedale San RaffaeleUnknownEndocrine Responsive Early Breast CancerItaly
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Early Stage Triple-Negative Breast CarcinomaUnited States, Puerto Rico
-
Dana-Farber Cancer InstituteWithdrawnBreast Cancer | Breast Neoplasms | Breast Carcinoma | Triple Negative Breast Cancer | Breast Cancer Stage II | Breast Cancer Stage III | Early Stage Triple-Negative Breast CarcinomaUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)CompletedLatent Phase Labour
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | HER-2 Gene Amplification | Breast Cancer Female | HER2 Positive Breast Carcinoma | HER-2 Protein OverexpressionUnited States
-
Spectros CorporationStanford University; University of California; Palo Alto Medical FoundationUnknownBreast Lesions | Early-Stage Breast Cancer | Breast Cyst | Benign Growth, BreastUnited States
-
University of ArizonaWithdrawnBreast Cancer | Gynecologic Cancer | Peripheral Neuropathy | Chemotherapy-induced Peripheral Neuropathy | Early-stage Breast CancerUnited States
-
Nij Smellinghe HosptialCompletedLymphedema | Breast Cancer Stage II | Early Disease OnsetNetherlands
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Early Stage Triple-Negative Breast CarcinomaUnited States, Puerto Rico
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Active, not recruitingStage 0 Breast Cancer | Cancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Early-Stage Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Adrienne G. WaksGilead SciencesRecruitingBreast Cancer Female | Breast Cancer Metastatic | Her 2 Positive Breast CancerUnited States
-
Dana-Farber Cancer InstituteThe Comprehensive and Integrative Medicine Institute of South KoreaCompletedStage I Breast Cancer | Stage II Breast Cancer | Early-Stage Breast Carcinoma | Stage III Breast Cancer | Chemotherapy-induced Peripheral Neuropathy (CIPN) | Taxane-induced Peripheral NeuropathyUnited States
-
AstraZenecaCompletedHER2-ve Metastatic Breast Cancer | Germline BRCA1/2 Mutations | Somatic BRCA1/2 MutationsItaly, Spain, Poland, Taiwan, Canada, France, Germany, Korea, Republic of, Hungary, Japan, Russian Federation, Turkey, United Kingdom, United States, Bulgaria
-
Saint John's Cancer InstituteRecruitingBreast Neoplasms | Early-stage Breast Cancer | Breast Carcinoma in SituUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Locally Advanced Breast Carcinoma | Early Stage Breast CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Early Stage Breast Carcinoma | Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Danish Breast Cancer Cooperative GroupRecruitingEarly Breast Cancer | Radiation Associated Cardiac FailureDenmark
-
Texas Tech University Health Sciences Center, El...WithdrawnBreast Cancer | Metastatic Breast Cancer | HER-2 Positive Breast Cancer | ER Positive Breast Cancer
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER-2 Positive Breast CancerBelgium, Netherlands, Australia, Italy, United States
-
Helse Stavanger HFCompletedInsulin Resistance | Estrogen Receptor-positive Breast Cancer | Early-stage Breast Cancer | Carbohydrate Engorgement | Proliferation
-
Technical University of MadridRecruitingEarly-stage Breast CancerSpain
-
University of California, San FranciscoCooler Heads Care Inc.RecruitingBreast Cancer | Alopecia | Chemotherapy-induced Alopecia | Early-stage Breast Cancer | Hair LossUnited States
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
Fudan UniversityUnknown
-
Zhimin ShaoRoche Pharma AGUnknownHER-2 Positive Breast CancerChina
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
Reshma L. Mahtani, D.O.Gilead SciencesRecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Hormone-receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Low Breast CancerUnited States
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonNot yet recruitingCancer | Diagnosis | Resistant Cancer | Response, Acute Phase
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States
-
Jewish General HospitalQuebec Breast Cancer FoundationRecruitingSentinel Lymph Node | Breast Cancer Female | Lymph Node Metastases | Early-stage Breast Cancer | Axillary MetastasesCanada
-
Henan Cancer HospitalQilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.Not yet recruitingHER-2 Negative Breast Cancer
-
Hospices Civils de LyonNot yet recruiting
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Istituto Scientifico Romagnolo per lo Studio e...Completed
-
Fudan UniversityUnknownHER-2 Negative Breast CancerChina
-
Instituto do Cancer do Estado de São PauloWithdrawnBreast Cancer | HER-2 Positive Breast CancerBrazil
-
Vector OncologyEisai Inc.TerminatedHER-2 Positive Breast CancerUnited States
-
GRAIL, LLCRecruitingCancer | Early Detection of CancerUnited States
-
GRAIL, LLCRecruitingCancer | Early Detection of CancerUnited States, Canada
-
Medstar Health Research InstituteGenentech, Inc.TerminatedHER-2 Positive Metastatic Breast CancerUnited States
-
Genor Biopharma Co., Ltd.UnknownHER-2-positive Advanced Breast CancerChina
-
Exact Sciences CorporationCompletedEarly Cancer DetectionUnited States
-
University of Michigan Rogel Cancer CenterGenentech, Inc.CompletedHER-2 Positive Metastatic Breast CancerUnited States